From leveling the AI playing field to advancing drone technology and medical diagnostics via wearables, 2025 will deliver new, efficient computer science-based solutions for consumers and businesses ...

How can businesses seize opportunities as the technology services industry emerges from its longest deceleration in years? Every year begins with questions about what lies ahead, and 2025 is no ...

People who have arthritis are probably already well aware of the ways chronic and fluctuating pain can seep into the day-to-day. Anything from a dull ache to a burning sensation can keep you from ...

is one of the largest global stages for companies to showcase their latest and greatest technology innovations. The renowned event highlights technologies from a wide range of sectors, including ...

Arthritis is a condition that causes inflammation and cartilage loss within the joint. There are several types of arthritis. The most common type—osteoarthritis, or wear-and-tear arthritis—occurs ...

MIT Technology Review’s What’s Next series looks across industries, trends, and technologies to give you a first look at the future. You can read the rest of them here. Every day, we are ...

AI is playing a critical role in revolutionising vision accessibility technology and creating smarter, more personalised solutions for people with visual impairments. The accuracy of AI-powered ...

GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase I drugs for Rheumatoid Arthritis have a 69% phase ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology. Introducing: MIT Technology Review’s 10 Breakthrough ...

(Guselkumab + golimumab) is under clinical development by Johnson & Johnson and currently in Phase II for Psoriatic Arthritis. According to GlobalData, Phase II drugs for Psoriatic Arthritis have an ...